Immunometabolism: an emerging frontier

Abstract

Immunometabolism is an emerging field of investigation at the interface between the historically distinct disciplines of immunology and metabolism. Accelerating interest in this area is being fuelled by the obesity epidemic and the relatively recent realization that obesity affects the immune system and promotes inflammation, and that obesity-induced inflammation potentially promotes a variety of chronic conditions and diseases. The multilevel interactions between the metabolic and immune systems suggest pathogenic mechanisms that may underlie many of the downstream complications of obesity and offer substantial therapeutic promise.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Ouchi, N., Parker, J. L., Lugus, J. J. & Walsh, K. Adipokines in inflammation and metabolic disease. Nature Rev. Immunol. 11, 85–97 (2011).

    CAS  Article  Google Scholar 

  2. 2

    Donath, M. Y. & Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nature Rev. Immunol. 11, 98–107 (2011).

    CAS  Article  Google Scholar 

  3. 3

    Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175–184 (2007).

    CAS  Article  Google Scholar 

  4. 4

    Ouchi, N. et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454–457 (2010).

    CAS  Article  Google Scholar 

  5. 5

    Larsen, C. M. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517–1526 (2007).

    CAS  Article  Google Scholar 

  6. 6

    Larsen, C. M. et al. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 32, 1663–1668 (2009).

    CAS  Article  Google Scholar 

  7. 7

    Goldfine, A. B. et al. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin. Transl. Sci. 1, 36–43 (2008).

    CAS  Article  Google Scholar 

  8. 8

    Fleischman, A., Shoelson, S. E., Bernier, R. & Goldfine, A. B. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31, 289–294 (2008).

    CAS  Article  Google Scholar 

  9. 9

    Goldfine, A. B. et al. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 152, 346–357 (2010).

    Article  Google Scholar 

  10. 10

    Finlay, D. & Cantrell, D. A. Metabolism, migration and memory in cytotoxic T cells. Nature Rev. Immunol. 11, 109–117 (2011).

    CAS  Article  Google Scholar 

  11. 11

    Nakada, D., Saunders, T. L. & Morrison, S. J. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 468, 653–658 (2010).

    CAS  Article  Google Scholar 

  12. 12

    Gurumurthy, S. et al. The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 468, 659–663 (2010).

    CAS  Article  Google Scholar 

  13. 13

    Gan, B. et al. Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 468, 701–704 (2010).

    CAS  Article  Google Scholar 

  14. 14

    Gallagher, E. J. & LeRoith, D. Insulin, insulin resistance, obesity, and cancer. Curr. Diab. Rep. 10, 93–100 (2010).

    CAS  Article  Google Scholar 

  15. 15

    Rothwell, P. M. et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377, 31–41 (2010).

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Ethics declarations

Competing interests

Diane Mathis is a member of the Scientific Advisory Boards of Tempero Pharmaceuticals and Catabasis Pharmaceuticals Inc.

Steven E. Shoelson holds patents on the use of salicylates in diabetes, prediabetes and cardiovascular disease. He has consulted for Catabasis, Amylin, AstraZeneca, Merck, Genentech, XOMA and Kowa

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mathis, D., Shoelson, S. Immunometabolism: an emerging frontier. Nat Rev Immunol 11, 81–83 (2011). https://doi.org/10.1038/nri2922

Download citation

Further reading

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing